L Prakash1*, Arvind Diwaker Jain2, Shabir Dhar3 and Sajid Jamal4
1Consultant Orthopaedic Surgeon, Palakkad, Kerala, India
2Consultant Orthopaedic Surgeon, Lalitpur, Uttar Pradesh, India
3Consultant Orthopaedic Surgeon, Srinagar, India
4Consultant Orthopaedic Surgeon, Calicut, Kerala, India
*Corresponding Author: L Prakash, Consultant Orthopaedic Surgeon, Palakkad, Kerala, India.
Received: May 11, 2021; Published: May 20, 2021
Pulmonary compromise and rapidly diminishing serum oxygen levels (SpO2), affects a significant number of patients suffering from Covid 19, and often necessities hospitalisation and administration of oxygen! Cytokine storm has been identified as one of the principal causes of this diminution of oxygen concentrations. Anti-inflammatory agents are known to assist in control of cytokine storms, and the current study is an observation of 2003 Covid 19 patients, who were administered 20 mg sublingual cuboidal crystals of Piroxicam daily for five days. 134 participating clinicians shared their experience with the molecule. It was observed that Piroxicam was capable of controlling cytokine storm, and rapidly improving oxygen saturation in over 90% of patients and the effect of a single tablet was sustained for over 24 hours.
Keywords: Sublingual Piroxicam; Hypoxia; Cytokine Storm; Covid 19 Pneumonia
Citation: L Prakash., et al. “Effect of Sublingual Piroxicam on Hypoxia in Cytokine Storm Induced Covid 19 Pneumonia - Descriptive Study of Clinicians’ Experiences in 2003 Consecutive Cases". Acta Scientific Orthopaedics 4.6 (2021): 78-81.
Copyright: © 2021 L Prakash., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.